World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
49165
World Ranking
2993
National Ranking
1658

Henry Mark Kuerer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Henry Mark Kuerer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 732 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Henry Mark Kuerer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Henry Mark Kuerer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Henry Mark Kuerer is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their work primarily focuses on medical research within the field of oncology, with a significant concentration on breast cancer treatment studies.

Their recent impactful publications include:

  • Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges, 2020, Annals of Oncology
  • Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial, 2022, The Lancet Oncology
  • Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer, 2020, JAMA Surgery
  • Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox, 2020, The Lancet Oncology
  • Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy, 2020, European Journal of Cancer

The areas of study for Henry Mark Kuerer cover broad medical disciplines as well as specialized subfields:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

The main research topics include:

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Breast Implant and Reconstruction
  • Cancer Genomics and Diagnostics
  • Global Cancer Incidence and Screening
  • Advanced Breast Cancer Therapies
  • Cancer Treatment and Pharmacology

Frequent co-authors working with Henry Mark Kuerer include:

  • Benjamin D. Smith
  • Kelly K. Hunt
  • Mediget Teshome
  • Susie X. Sun
  • Abigail S. Caudle

The scientist has contributed extensively to several publication venues, including:

  • Annals of Surgical Oncology
  • European Journal of Surgical Oncology
  • Cancer Research
  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology

Best Publications

  • Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

    W. Fraser Symmans;Florentia Peintinger;Christos Hatzis;Radhika Rajan

  • Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    Henry M. Kuerer;Lisa A. Newman;Terry L. Smith;Fred C. Ames

  • Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

    Judy C. Boughey;Vera J. Suman;Elizabeth A. Mittendorf;Gretchen M. Ahrendt

  • Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

    Abigail S. Caudle;Wei T. Yang;Savitri Krishnamurthy;Elizabeth A. Mittendorf

  • Circulating tumour cells in non-metastatic breast cancer: a prospective study

    Anthony Lucci;Carolyn S Hall;Ashutosh K. Lodhi;Anirban Bhattacharyya

  • Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.

    Roman Rouzier;Radhika Rajan;Peter Wagner;Kenneth R. Hess

  • Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

    Y. Xing;M. Foy;D. D. Cox;H. M. Kuerer

  • Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

    Bryan T. Hennessy;Gabriel N. Hortobagyi;Roman Rouzier;Henry Kuerer

  • Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero

    Karin M.E. Hahn;Peter H. Johnson;Nancy Gordon;Henry Kuerer

  • Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform

    Kevin R. Coombes;Spiridon Tsavachidis;Jeffrey Morris;Keith A Baggerly

  • Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.

    Allen M. Chen;Funda Meric-Bernstam;Kelly K. Hunt;Howard D. Thames

  • Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes

    Massimo Cristofanilli;Ana Gonzalez-Angulo;Nour Sneige;Shu Wan Kau

  • Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites

    Funda Meric;Elmer V Bernstam;Nadeem Q Mirza;Kelly K Hunt

  • RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

    Beryl McCormick;Kathryn Winter;Clifford Hudis;Henry Mark Kuerer

  • Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma

    Savitri Krishnamurthy;Nour Sneige;Deepak G. Bedi;Beth S. Edieken

  • Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.

    Henry M. Kuerer;Aysegul A. Sahin;Kelly K. Hunt;Lisa A. Newman

  • Delayed-immediate breast reconstruction.

    Steven J. Kronowitz;Kelly K Hunt;Henry Mark Kuerer;Gildy Babiera

  • Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

    Frank A Vicini;Reena S Cecchini;Julia R White;Douglas W Arthur

  • Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.

    Kelly K. Hunt;Min Yi;Elizabeth A. Mittendorf;Cynthia Guerrero

  • Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.

    Tina W.F. Yen;Kelly K. Hunt;Merrick I. Ross;Nadeem Q. Mirza

Frequent Co-Authors

Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
Gildy Babiera
Gildy Babiera The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Merrick I. Ross
Merrick I. Ross The University of Texas MD Anderson Cancer Center
S. Eva Singletary
S. Eva Singletary The University of Texas MD Anderson Cancer Center
Thomas A. Buchholz
Thomas A. Buchholz The University of Texas MD Anderson Cancer Center
Elizabeth A. Mittendorf
Elizabeth A. Mittendorf Brigham and Women's Hospital
Anthony Lucci
Anthony Lucci The University of Texas MD Anderson Cancer Center
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Savitri Krishnamurthy
Savitri Krishnamurthy The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine or healthcare doesn’t always mean following the traditional path of an MD program. There are a range of which online healthcare administration programs have cahme accreditation? that can lead to roles in hospital management, policy, and healthcare leadership. These CAHME-accredited programs ensure high standards and open doors to top administrative positions.

For nurses, options are expanding beyond campus-based programs. If you're already an RN, you may be interested in learning about rn to bsn online with no clinicals, which allow you to advance your credentials without in-person clinical requirements—ideal for working professionals.

Those aiming for doctoral-level roles will find a variety of accelerated online nursing doctorates. To help you compare, explore the shortest dnp programs online as well as the shortest dnp program options, both designed to help you achieve your goals faster.

Online degrees offer flexibility and diverse specializations—making it easier than ever to launch or advance a healthcare career beyond traditional medical school.

Best Scientists Citing Henry Mark Kuerer

Trending Scientists

Recently Published Articles